Cibus (CBUS) vs Evogene (EVGN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Cibus is the larger company by market cap ($92.7 million vs $5.7 million), about 16.2 times the size. Evogene converts more of its revenue into profit, with a net margin of -220.2% versus -3492.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CBUS | EVGN |
|---|---|---|
| Share price | $1.21 | $0.3162 |
| Market cap | $92.73M | $5.71M |
| 1-day change | -1.63% | +1.02% |
| YTD return | -30.46% | — |
| 1-year return | -3.97% | — |
| 5-year return | -99.22% | — |
| EPS (TTM) | $-1.46 | $-1.55 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $3.64M | $3.85M |
| Revenue growth (YoY) | -14.62% | -30.91% |
| Net income (latest FY) | $-127.08M | $-8.48M |
| Gross margin | — | -6.25% |
| Operating margin | -2680.10% | -364.24% |
| Net margin | -3492.31% | -220.22% |
| 52-week high | $4.19 | $1.26 |
| 52-week low | $1.02 | $0.25 |
| Distance from 52-week high | -71.13% | -74.90% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +891.74% | +579.95% |
| Average volume | 117.21K | 1.40M |
| Shares outstanding | 76.64M | 18.05M |
| Employees | 118 | 38 |
| Sector | Industrials | Industrials |
| Industry | Agricultural Chemicals | Agricultural Chemicals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cibus is about 16.2 times larger than Evogene by market value ($92.73M vs $5.71M).
- Evogene is more profitable, keeping -220.2 cents of every revenue dollar as net income versus -3492.3 cents for Cibus.
- Cibus grew revenue faster in its latest fiscal year (-14.62% vs -30.91%).
About Cibus
CBUS stock →Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits.
Industrials · Agricultural Chemicals · 118 employees
About Evogene
EVGN stock →Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications.
Industrials · Agricultural Chemicals · 38 employees
CBUS vs EVGN FAQ
Which is bigger, Cibus or Evogene?
Cibus (CBUS) is larger, with a market capitalization of $92.73M compared with $5.71M for Evogene (EVGN).
Are Cibus and Evogene in the same industry?
Yes. Both are classified in the Agricultural Chemicals industry within the Industrials sector.